BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15095125)

  • 21. Is there a role for defensins in IBD?
    Wehkamp J; Stange EF
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S85-7. PubMed ID: 18816709
    [No Abstract]   [Full Text] [Related]  

  • 22. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense.
    Wehkamp J; Stange EF
    Ann N Y Acad Sci; 2006 Aug; 1072():321-31. PubMed ID: 17057212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defensins Potentiate a Neutralizing Antibody Response to Enteric Viral Infection.
    Gounder AP; Myers ND; Treuting PM; Bromme BA; Wilson SS; Wiens ME; Lu W; Ouellette AJ; Spindler KR; Parks WC; Smith JG
    PLoS Pathog; 2016 Mar; 12(3):e1005474. PubMed ID: 26933888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intestinal flora and Crohn's disease].
    Desreumaux P; Colombel JF
    Ann Pharm Fr; 2003 Jul; 61(4):276-81. PubMed ID: 12843962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defensins and other antimicrobial peptides in inflammatory bowel disease.
    Wehkamp J; Schmid M; Stange EF
    Curr Opin Gastroenterol; 2007 Jul; 23(4):370-8. PubMed ID: 17545771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced Paneth cell alpha-defensins in ileal Crohn's disease.
    Wehkamp J; Salzman NH; Porter E; Nuding S; Weichenthal M; Petras RE; Shen B; Schaeffeler E; Schwab M; Linzmeier R; Feathers RW; Chu H; Lima H; Fellermann K; Ganz T; Stange EF; Bevins CL
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18129-34. PubMed ID: 16330776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced mucosal antimicrobial activity in Crohn's disease of the colon.
    Nuding S; Fellermann K; Wehkamp J; Stange EF
    Gut; 2007 Sep; 56(9):1240-7. PubMed ID: 17456510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective innate immunity in inflammatory bowel disease: a Crohn's disease exclusivity?
    Marks DJ
    Curr Opin Gastroenterol; 2011 Jul; 27(4):328-34. PubMed ID: 21483259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel role for defensins in intestinal homeostasis: regulation of IL-1beta secretion.
    Shi J; Aono S; Lu W; Ouellette AJ; Hu X; Ji Y; Wang L; Lenz S; van Ginkel FW; Liles M; Dykstra C; Morrison EE; Elson CO
    J Immunol; 2007 Jul; 179(2):1245-53. PubMed ID: 17617617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa.
    Cunliffe RN; Kamal M; Rose FR; James PD; Mahida YR
    J Clin Pathol; 2002 Apr; 55(4):298-304. PubMed ID: 11919217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of a 'Leaky' Intestinal Barrier.
    Stange EF
    Dig Dis; 2017; 35(1-2):21-24. PubMed ID: 28147355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathogenesis of chronic inflammatory bowel diseases].
    Kreisel W
    Praxis (Bern 1994); 2006 Dec; 95(50):1965-73. PubMed ID: 17256276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
    Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
    Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
    Agius LM
    J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of human defensins in gastrointestinal diseases.
    Langhorst J; Choi KE
    Expert Rev Clin Immunol; 2011 Nov; 7(6):779-87. PubMed ID: 22014019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteria in the pathogenesis of inflammatory bowel disease.
    Subramanian S; Campbell BJ; Rhodes JM
    Curr Opin Infect Dis; 2006 Oct; 19(5):475-84. PubMed ID: 16940872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons from genetic models of inflammatory bowel disease.
    Podolsky DK
    Acta Gastroenterol Belg; 1997; 60(2):163-5. PubMed ID: 9260328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From intestinal stem cells to inflammatory bowel diseases.
    Gersemann M; Stange EF; Wehkamp J
    World J Gastroenterol; 2011 Jul; 17(27):3198-203. PubMed ID: 21912468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crohn's disease--defect in innate defence.
    Gersemann M; Wehkamp J; Fellermann K; Stange EF
    World J Gastroenterol; 2008 Sep; 14(36):5499-503. PubMed ID: 18810765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of human beta-defensins in children with chronic inflammatory bowel disease.
    Zilbauer M; Jenke A; Wenzel G; Postberg J; Heusch A; Phillips AD; Noble-Jamieson G; Torrente F; Salvestrini C; Heuschkel R; Wirth S
    PLoS One; 2010 Oct; 5(10):e15389. PubMed ID: 21042595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.